Bacil Pharma has informed that the Extra-Ordinary General meeting of the Company held on Thursday, November 14, 2024 through Video Conferencing (VC)/Other audio-visual Means (OAVM). It enclosed, Voting Results as required under Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015; Scrutinizer Report on E-Voting as per the provisions of Section 108 and 109 of the Companies Act, 2013 read with Companies (Management and Administration) Rules, 2014.
The above information is a part of company’s filings submitted to BSE.